June 10, 2025

Study Tests New Clot Removal Access Route

A new clinical trial is investigating whether removing clots using a modified access point can better prevent post-thrombotic syndrome in patients with extensive deep vein thrombosis.

Conexiant

June 10, 2025

FDA Pledges Week-Long Drug Reviews

New leadership outlines accelerated approval processes, AI integration, and food additive restrictions to address the chronic disease epidemic

Conexiant

June 06, 2025

RSV or COVID: Which Strains the Heart?

A study of 32,960 hospitalizations finds 10.9% of patients with RSV experienced acute cardiovascular events, with significantly higher adjusted odds than boosted and unboosted COVID-19 cases.

Conexiant

June 05, 2025

Water Loss Test May Predict Ulcer Recurrence

Researchers found that measuring skin water loss at healed diabetic foot ulcers can help predict which wounds are more likely to reopen.

Conexiant

June 04, 2025

Medical Oddities: Legumes Over Lipids?

From ticklish brains to bean-powered cholesterol drops, here’s what made the medical rounds weirdly wonderful this week.

Conexiant

May 29, 2025

Mid Atlantic Conference: Concepts in Cardiology 2025

Don’t miss the most comprehensive course designed for cardiology providers, cardiologists,  interventional cardiologists, electrophysiologists, nurses, NPs, PAs, and technologists, and students on strategies for managing cardiovascular care. 

Sentara

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 23, 2025

New Inhaled Treprostinil Option Approved

Yutrepia represents an additional therapeutic option within the prostacyclin class for the management of PAH and PH-ILD.

Conexiant

May 23, 2025

Patients With Psoriasis Show Inflammation Despite Skin Clearance

Over one-third of psoriasis patients had elevated hs-CRP despite biologic treatment and skin clearance, with obesity, female sex, and fatty liver disease identified as key predictors of residual inflammation.

Conexiant